Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Serina Therapeutics, Inc. (SER) had Return on Equity of 386.08% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.13M |
|
$-19.18M |
|
-- |
|
$0.13M |
|
$24.15M |
|
$-24.02M |
|
$4.83M |
|
$-19.20M |
|
$-19.20M |
|
$-19.21M |
|
$-19.21M |
|
$-19.21M |
|
$-19.21M |
|
$-24.02M |
|
$-23.89M |
|
10.19M |
|
10.19M |
|
$-1.91 |
|
$-1.91 |
|
| Balance Sheet Financials | |
$6.08M |
|
$0.47M |
|
$0.87M |
|
$6.95M |
|
$3.56M |
|
$2.95M |
|
$3.42M |
|
$6.99M |
|
$-4.98M |
|
$-0.04M |
|
$-0.04M |
|
10.77M |
|
| Cash Flow Statement Financials | |
$-17.95M |
|
$-0.06M |
|
$17.41M |
|
$3.67M |
|
$3.06M |
|
$-0.62M |
|
$3.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.71 |
|
-- |
|
-- |
|
1.01 |
|
-79.62 |
|
100.00% |
|
-18478.46% |
|
-18478.46% |
|
-18377.69% |
|
-14766.92% |
|
-14755.38% |
|
$-18.01M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
386.08% |
51932.85% |
|
-276.44% |
|
-660.54% |
|
$-0.00 |
|
$-1.77 |
|
$-1.76 |
|